Miami Cancer Institute – New Advances in the Management of Pancreatic Cancer

Pancreatic cancer is a malignancy with poor prognosis and high mortality. The risk factors can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. During this conference, a panel of experts that includes Dr. Domenech Asbun, Dr. Horacio Asbun, Dr. Michael Chuong, Dr. Ripal Gandhi, Dr. Ramon Jimenez and Dr. Govindarajan Narayanan, will examine recently published trial data and review their implications for unresectable locally advanced pancreatic cancer care. 

This course also includes an interactive case which  walks learners through a real-life scenario to assess the patient's history, review evidence-based data supporting best practices in pancreatic cancer care and answer questions about the factors in identifying, diagnosing, and treating pancreatic cancer. 

Target Audience

Internists, Hospitalists, General Practitioners, Gastroenterologists, General Surgeons, Emergency Department Physicians, Obstetricians and Gynecologists, Oncologists, Radiation Oncologists, Physician Assistants, Advanced Practice Registered Nurses, Nurses, Patient Navigators and all other interested healthcare professionals.  

Learning Objectives

  • Examine recently published trial data and review their implications for unresectable locally advanced pancreatic cancer care. 
  • Identify and recognize new clinical data that support total neoadjuvant therapy in pancreatic cancer.  
  • Recognize the need for gastrointestinal follow-up for pancreatic cancer patients.
  • Screen patients who present to the emergency department with symptoms associated with possible diagnosis of pancreatic cancer.  
  • Recognize patients who would benefit from receiving abdominal imaging to rule out pancreatic tumors or disease. 
Additional information
Bibliography: 
  • Dutcher, J. S., Asbun, D., Tice, M. P., Asbun, H. J., & Stauffer, J. A. (2021). Updated outcomes using clockwise technique for laparoscopic distal pancreatectomy: Optimal treatment of benign and malignant disease of the left pancreas. Laparoscopic, Endoscopic and Robotic Surgery, 4(1), 9-13
  • Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., ... & Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. New England Journal of Medicine, 369(18), 1691-1703.
  • Iacobuzio-Donahue, C. A., Fu, B., Yachida, S., Luo, M., Abe, H., Henderson, C. M., ... & Laheru, D. (2009). DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. Journal of clinical oncology, 27(11), 1806.
  • Chuong, M. D., Bryant, J., Mittauer, K. E., Hall, M., Kotecha, R., Alvarez, D., ... & Gutierrez, A. N. (2021). Ablative 5-fraction stereotactic magnetic resonance–guided radiation therapy with on-table adaptive replanning and elective nodal irradiation for inoperable pancreas cancer. Practical Radiation Oncology, 11(2), 134-147.
  • Rudra, S., Jiang, N., Rosenberg, S. A., Olsen, J. R., Roach, M. C., Wan, L., ... & Lee, P. P. (2019). Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer medicine, 8(5), 2123-2132.
  • Zhang, L., Sanagapalli, S., & Stoita, A. (2018). Challenges in diagnosis of pancreatic cancer. World journal of gastroenterology, 24(19), 2047–2060.
  • Zaheer, A., Singh, V. K., Qureshi, R. O., & Fishman, E. K. (2013). The revised Atlanta classification for acute pancreatitis: updates in imaging terminology and guidelines. Abdominal imaging, 38(1), 125–136.
  • Asbun, H. J., Conlon, K., Fernandez-Cruz, L., Friess, H., Shrikhande, S. V., Adham, M., Bassi, C., Bockhorn, M., Büchler, M., Charnley, R. M., Dervenis, C., Fingerhutt, A., Gouma, D. J., Hartwig, W., Imrie, C., Izbicki, J. R., Lillemoe, K. D., Milicevic, M., Montorsi, M., Neoptolemos, J. P., … International Study Group of Pancreatic Surgery (2014). When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery, 155(5), 887–892.
  • Shaib, W. L., Narayan, A. S., Switchenko, J. M., Kane, S. R., Wu, C., Akce, M., Alese, O. B., Patel, P. R., Maithel, S. K., Sarmiento, J. M., Kooby, D. A., & El-Rayes, B. F. (2019). Role of adjuvant therapy in resected stage IA subcentimeter (T1a/T1b) pancreatic cancer. Cancer, 125(1), 57–67.

Related Topics

Miami Cancer Institute Online Series (Multiple Modules)
This online educational series features Miami Cancer Institute (MCI) physician experts and national subject matter experts who have presented at our recent symposiums. Topics highlight the latest advances in cancer imaging, chemotherapy, surgical interventions, radiotherapy and proton therapy. Visit us often, as this catalog will be updated frequently.
Course Summary
Available credit: 
  • 2.50 ABS MOC II
  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 General certificate of attendance
  • 2.50 Nurse Practitioners
  • 2.50 Florida Board of Nursing
Course opens: 
02/01/2022
Course expires: 
01/31/2024
Cost:
$9.95

Domenech Asbun, M.D.
Hepatobiliary and Pancreatic Surgery
Miami Cancer Institute
Miami, Florida

Ramon E. Jimenez, M.D.
Surgical Oncology
Sarcoma and Connective Tissue Surgical Oncology
Miami Cancer Institute

Domenech Asbun, M.D., and Ramon E. Jimenez, M.D., faculty for this educational activity, have no relevant financial relationships with ineligible companies* to disclose and have indicated that the presentations or discussions will not include off-label or unapproved product usage.

Horacio J. Asbun, M.D.  
Chief of Hepatobiliary & Pancreatic Surgery
Baptist Health Medical Group, Miami Cancer Institute, Baptist Health South Florida

Horacio J. Asbun, M.D., faculty and content reviewer for this educational event, is a consultant with Verb, Johnson & Johnson, Boston Scientific and Olympus, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.  

Michael Chuong, M.D., FACRO 
Medical & Clinical Research Director
GI Service Lead, Dept. of Radiation Oncology, Miami Cancer Institute
Associate Professor, Vice Chair of Research and Education
Florida International University

Michael Chuong, M.D., FACRO, faculty for this educational activity, is a researcher for ViewRay, Novocure and AstraZeneca; a consultant and adviser for ViewRay; an adviser for Advanced Accelerator Applications; and a member of the speakers’ bureau for ViewRay, Elekta and Sirtex. Dr. Chuong has indicated that the presentation or discussion will not include off-label or unapproved product usage. 

Ripal Gandhi, M.D.
Miami Cancer Institute and Miami Cardiac & Vascular Institute
Associate Clinical Professor, Florida International University Herbert Wertheim College of Medicine
Associate Clinical Professor, University of South Florida School of Medicine

Ripal Gandhi, M.D., conference director and faculty for this educational activity, is a consultant for Sirtex, Medtronic, BD, Cordis and TriSalus Life Sciences, and has indicated that the presentation or discussion will include off-label or unapproved product usage. 

Govindarajan Narayanan, M.D.
Chief of Interventional Oncology
Baptist Health South Florida
Professor of Radiology
Florida International University Herbert Wertheim College of Medicine

Govindarajan Narayanan, M.D., faculty for this educational activity, is a consultant with Angiodynamics, Varian, Boston Scientific, Stryker and Guerbet, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.  

J. Arturo Fridman, M.D.
Medical Director
Continuing Medical Education
Baptist Health South Florida
Associate Professor of Surgery
Wertheim College of Medicine
Florida International University

J. Arturo Fridman, M.D, author of the case scenario, has no relevant financial relationship with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage. 

Filipe Kunzler, M.D.
Fellow in Hepato-Billiary and Pancreatic Surgery
Miami Cancer Institute 
Baptist Health South Florida

Filipe Kunzler, M.D., contributor to the case scenario, has no relevant financial relationship with ineligible companies* to disclose, and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

All relevant financial relationships listed for these individuals have been mitigated. 

Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

image

American Board of Surgery - Maintenance of Certification (MOC) - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Successful completion of a course examination is required. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.

Available Credit

  • 2.50 ABS MOC II
  • 2.50 AMA PRA Category 1 Credit™
  • 2.50 General certificate of attendance
  • 2.50 Nurse Practitioners
  • 2.50 Florida Board of Nursing

Price

Cost:
$9.95
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome		Microsoft Edge
Microsoft Edge		Safari
Safari		Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.